Literature DB >> 3687925

External comparisons with the case-cohort design.

S Wacholder1, J F Boivin.   

Abstract

The case-cohort design can be an economic alternative to the standard cohort design. Prentice (Biometrika 1986;73:1-11) showed how the case-cohort design can be used to obtain relative risk estimates for comparisons within the cohort being studied. In this paper, the authors consider ways in which the case-cohort design can be used for comparing risk in exposure groups within the cohort to the risk in an external population. The problem reduces to estimating the number of expected cases at each exposure level in the total cohort, when exposure status is available only for members of a subcohort, i.e., a random sample of the total cohort. The authors describe theoretical and empirical properties of several variations of the design and analysis of case-cohort studies. Empirical properties were examined by replicating the selection of the subcohort in a study of second cancer risk after chemotherapy for a first cancer. Use of a case-cohort design in that study would have saved five-sixths of the cost of gathering covariate information at the price of only an 11% loss in efficiency relative to a full cohort study.

Entities:  

Mesh:

Year:  1987        PMID: 3687925     DOI: 10.1093/oxfordjournals.aje.a114759

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  12 in total

1.  The case-population study design: an analysis of its application in pharmacovigilance.

Authors:  Hélène Théophile; Joan-Ramon Laporte; Nicholas Moore; Karin-Latry Martin; Bernard Bégaud
Journal:  Drug Saf       Date:  2011-10-01       Impact factor: 5.606

2.  Risk of cancer of the breast after legal abortion during first trimester: a Swedish register study.

Authors:  B M Harris; G Eklund; O Meirik; L E Rutqvist; K Wiklund
Journal:  BMJ       Date:  1989-12-09

3.  To use or not to use the odds ratio in epidemiologic analyses?

Authors:  M Nurminen
Journal:  Eur J Epidemiol       Date:  1995-08       Impact factor: 8.082

4.  Cancer incidence among workers occupationally exposed to dinitrotoluene in the copper mining industry.

Authors:  Andreas Seidler; Thomas Brüning; Dirk Taeger; Matthias Möhner; Katarzyna Gawrych; Annekatrin Bergmann; Johannes Haerting; Hermann Maximilian Bolt; Kurt Straif; Volker Harth
Journal:  Int Arch Occup Environ Health       Date:  2012-12-30       Impact factor: 3.015

5.  Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.

Authors:  I Persson; H O Adami; L Bergkvist; A Lindgren; B Pettersson; R Hoover; C Schairer
Journal:  BMJ       Date:  1989-01-21

Review 6.  Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis.

Authors:  Jonathan Z Li; Roger Paredes; Heather J Ribaudo; Evguenia S Svarovskaia; Karin J Metzner; Michael J Kozal; Kathy Huppler Hullsiek; Melanie Balduin; Martin R Jakobsen; Anna Maria Geretti; Rodolphe Thiebaut; Lars Ostergaard; Bernard Masquelier; Jeffrey A Johnson; Michael D Miller; Daniel R Kuritzkes
Journal:  JAMA       Date:  2011-04-06       Impact factor: 56.272

Review 7.  Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure.

Authors:  Jonathan Z Li; Roger Paredes; Heather J Ribaudo; Evguenia S Svarovskaia; Michael J Kozal; Katherine H Hullsiek; Michael D Miller; David R Bangsberg; Daniel R Kuritzkes
Journal:  AIDS       Date:  2012-01-14       Impact factor: 4.177

8.  Selenium and the risk of postmenopausal breast cancer in the DOM cohort.

Authors:  P A van Noord; M J Maas; I van der Tweel; C Collette
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

9.  Cluster-Randomized Test-Negative Design Trials: A Novel and Efficient Method to Assess the Efficacy of Community-Level Dengue Interventions.

Authors:  Katherine L Anders; Zoe Cutcher; Immo Kleinschmidt; Christl A Donnelly; Neil M Ferguson; Citra Indriani; Peter A Ryan; Scott L O'Neill; Nicholas P Jewell; Cameron P Simmons
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

10.  Intact and C-Terminal FGF23 Assays-Do Kidney Function, Inflammation, and Low Iron Influence Relationships With Outcomes?

Authors:  Shilpa Sharma; Ronit Katz; Alexander L Bullen; Paulo H M Chaves; Peter W de Leeuw; Abraham A Kroon; Alfons J H M Houben; Michael G Shlipak; Joachim H Ix
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.